We focus on sectors that have strong decades-long tailwinds, where we have direct experience and where we can leverage our strong external networks to create value.
- High Performance Semiconductors
- Cellular Infrastructure
- Storage infrastructure
- Data Analytics/Artificial Intelligence
- Internet of Things (IoT)
- Therapeutics and medical devices across the following clinical indications:
- Respiratory Diseases
- Infectious Diseases
Focused on the commercialization of spectacles with digital lens technology.Visit Website
Utilizes diamond crystals to enable secure identification of physical objects.Visit Website
Focused on developing an organic photodetector material (OPD) for several commercial applications.Visit Website
Focused on generating higher quality atmospheric data through the design of a new satellite-deployed instrument.Visit Website
Focused on the development of a first-in-class oncology therapeutic.Visit Website
Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.Visit Website
Acquired by Agilent Technologies. Developer of tools for measuring cell metabolism.
Acquired by Welsh, Carson, Anderson & Stowe. Developer of solutions for the treatment of complex spinal pathologies.
Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.
Acquired by Amgen. Focused on the development of a small molecule therapy for dyslipidemia.
Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.
Acquired by Cephalon. Focused on the development of a biologic therapy for the treatment of asthma.
Acquired by Amgen. Focused on the development of an oncolytic vaccine for melanoma and head and neck cancer.
Acquired by Allergan. Focused on the development of a small molecule therapy for the treatment of NASH.
Focused on the development of a drug-based solution to reduce the failure rate of AV Fistulas in dialysis patients.Visit Website
Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.Visit Website
Developer of SuperSaturated Oxygen (SSO2) therapy to complement percutaneous coronary intervention.Visit Website
Focused on the development of monoclonal antibody mixture therapies for oncology indications.Visit Website
Developer of a radial drug-eluting stent platform to simplify cardiovascular stenting procedures.Visit Website
Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.Visit Website
Focused on the development of a small molecule therapy for atopic dermatitis.Visit Website
Provider of an automated solution for pharmacy pill-dispensing.Visit Website
Focused on the development of next-generation enzyme replacement therapies for lysosomal storage diseases based on a yeast-based platform.Visit Website
Provider of digital holographic microscopy technology.Visit Website
Focused on the development of a small molecule therapy for inflammatory bowel disease.Visit Website
Focused on the development of small molecule therapies for psoriasis.Visit Website
Focused on the development of tools for epigenetic analysis.Visit Website
Acquired by Audience. Developer of algorithms and software enabling consumer applications to better understand user contexts and intent.
Acquired by Cisco. Developer of advanced optical interconnect technology for high-speed networking applications.
Developer of a platform to allow telco operators to monetize their data securely and at scale.Visit Website
Analytical instrumentation company focused on exploiting the vacuum UV band of the spectrum.Visit Website
Provider of a patent-protected, process-based approach to harden semiconductor devices against radiation and thermal damage.Visit Website
Acquired by CyberArk. Provider of encryption-in-use technology which enables businesses to encrypt their data before it goes to the cloud.
Provider of a texting solution that is easy to use, flexible, easy to learn, and HIPAA (Health Insurance Portability and Accountability Act of 1996) compliant.Visit Website
Provider of high performance based storage software for real-time, big data, cloud, HPC, and other highly demanding data center applications.Visit Website
Supplier of thin and flexible power solutions.Visit Website
Focused on the development of therapies for hard and soft tissue reconstruction from autologous adipose stem cells.Visit Website
Provider of a molecular diagnostic test to guide clinical decision making for cancer patientsVisit Website
Focused on the development of a non-viral gene therapy for advanced peripheral artery disease.Visit Website
Supplier of an innovative inkjet-based printing solution to enable printing of large-format organic light-emitting diodes (OLEDs) on a mass-production basis.Visit Website
Focused on creating single chip switching voltage regulators that are small, fast and efficient.Visit Website
Big data business analytics company focused on in-database analytics.Visit Website
Developer of a proprietary publishing platform that offers a comprehensive digital, web, and mobile publishing solution.Visit Website
Creator of a platform to provide mobile data service coverage that is scalable to the growth of mobile data demand.Visit Website
Focused on changing the economics of content storage and managing data through software designed object storage.Visit Website
Focused on the development of molecular assessments to improve the management of chronic diseases, with an initial focus on COPD.Visit Website
Provider of cancer detection and radiation therapy solutions.Visit Website
Supplier of embedded field programmable gate array (eFPGA) technology.Visit Website